SCHEMBL19832018

SCHEMBL19832018

O=C(OCc1ccccc1)N(O)Cc1ccccc1

nearest known ligand 0.54

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
ALOX5 P09917 4/20 0.54
PTGS1 P23219 1/20 0.54
PTGS2 P35354 1/20 0.54
ALDH1A1 P00352 5/20 0.53
TDP1 Q9NUW8 2/20 0.52
MAPK1 P28482 1/20 0.52
L3MBTL1 Q9Y468 1/20 0.52
SLC6A2 P23975 1/20 0.52
SLC6A3 Q01959 1/20 0.52
KMT2A Q03164 1/20 0.52
RIPK1 Q13546 1/20 0.47
LMNA P02545 2/20 0.47
HCAR2 Q8TDS4 1/20 0.47
CCR6 P51684 1/20 0.47
PAX8 Q06710 1/20 0.47
MAPT P10636 1/20 0.45
HPGD P15428 1/20 0.45
MMP2 P08253 1/20 0.44
MMP9 P14780 1/20 0.44
MMP12 P39900 1/20 0.44

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL28575124 0.84 ALDH1A1 (0.52) ALOX5PTGS1PTGS2ALDH1A1TDP1
SCHEMBL11042276 0.84 ALDH1A1 (0.62) ALOX5PTGS1PTGS2ALDH1A1L3MBTL1
SCHEMBL27364470 0.83 CCR6 (0.55) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL8604257 0.83 ALDH1A1 (0.55) ALOX5PTGS1PTGS2ALDH1A1TDP1
SCHEMBL668388 0.82 ALDH1A1 (0.59) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL6827731 0.81 ALDH1A1 (0.53) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL7386721 0.81 ALDH1A1 (0.53) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL7152866 0.80 ALDH1A1 (0.52) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL13687204 0.80 CHRNB2 (0.61) ALDH1A1TDP1MAPK1L3MBTL1SLC6A2
SCHEMBL4959369 0.80 CYP3A4 (0.49) ALOX5PTGS1PTGS2ALDH1A1L3MBTL1

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 1 patent. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
EP-3016685-B1 SYNTHETIC OLIGOSACCHARIDES FOR P. AERUGINOSA VACCINE VISTERRA INC (US) 2018-01-31 EP disclosed